Walking Fish Therapeutics
San Francisco
About Walking Fish Therapeutics
Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system in the treatment of cancer, and to serve as in vivo protein factories that produce replacement proteins for deficiency diseases, regenerative proteins, and engineered antibodies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $50K – $100K
- Total funding: $73.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Feb 2022)
- Website: walkingfishtx.com
- Phone: (650) 392-0422
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/walking-fish-therapeutics-2417 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.